查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1696281

全球血液加溫設備市場 - 2025 至 2033 年

Global Blood Warmer Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球血液加溫設備市場規模達到 13.8 億美元，預計到 2033 年將達到 121.1 億美元，2025-2033 年預測期內的複合年成長率為 24.2%。

血液加溫裝置是一種醫療設備，可在給患者輸注血液和靜脈液之前提高其溫度，防止在手術、創傷護理或大量輸血期間出現體溫過低的情況。它們確保液體與患者的體溫相匹配，從而減少心律不整和凝血病等併發症。它們廣泛應用於醫院、緊急醫療服務、軍事環境和重症監護室，以提高患者安全性並改善臨床結果。

市場動態：

促進因素與約束因素

低溫症盛行率不斷上升

全球血液加溫設備市場正在不斷成長，因為體溫過低的盛行率日益增加，體溫過低是外科手術、創傷病例和緊急醫療情況下的常見風險。醫療機構擴大採用血液加溫裝置，以確保在輸液和輸血過程中安全有效地調節溫度。人們對體溫過低相關風險的認知不斷提高，以及血液加溫技術的進步，正在推動市場需求，使得這些設備成為現代醫療保健中必不可少的設備。

例如，根據 NCBI 2024 年的研究，在美國，每年發生 700-1500 起與體溫過低有關的死亡事件，主要影響 30-49 歲的成年人，男性的發生率高出 10 倍。儘管住院護理得到最佳化，中度至重度低溫症的死亡率仍接近 50%。

先進血液加溫裝置成本高昂

先進的血液加溫設備成本高昂，特別是在中低收入國家，阻礙了市場的成長。這些設備需要大量投資，小型醫療機構和緊急服務機構不容易獲得。維護、一次性配件和法規遵循的成本增加了醫療保健提供者的財務負擔。這種可負擔性障礙限制了其廣泛採用，特別是在醫療資金不足的地區。為了克服這個問題，需要採取降低價格、政府支持和具有成本效益的解決方案等策略性努力，以提高可近性並改善全球患者護理。

例如，血液加溫器是輸血前加熱血液和靜脈液、防止體溫過低和提高病人安全性的重要醫療工具。印度的價格根據品牌、功能和技術而有所不同，從基本型號的 250 美元到高級系統的 2,000 美元不等。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類
  • 技術片段
  • 最終用戶的程式碼片段
  • 按地區分類

第 3 章：動態

  • 影響因素
    • 驅動程式
      • 低溫症盛行率不斷上升
      • 攜帶式和電池供電血液加溫器技術的進步
    • 限制
      • 先進血液加溫裝置成本高昂
      • 嚴格的監管批准和合規要求
    • 機會
      • 物聯網和基於人工智慧的監控系統整合，實現精確溫度控制
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有銷售量最大的品牌的既定領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 5 章：依產品類型

  • 手提式血液加溫器
  • 非攜帶式血液加溫器

第 6 章：按技術

  • 乾熱板加熱器
  • 水浴加熱器
  • 紅外線暖器

第 7 章：按最終用戶

  • 醫院和診所
  • 門診手術中心
  • 緊急醫療服務

第 8 章：區域市場分析與成長機會

  • 北美洲
    • 各區域關鍵動態
      • 美國
      • 加拿大
  • 歐洲
    • 各區域關鍵動態
      • 德國
      • 英國
      • 法國
      • 西班牙
      • 義大利
      • 歐洲其他地區
  • 拉丁美洲
    • 各區域關鍵動態
      • 墨西哥
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地區
  • 亞太
    • 各區域關鍵動態
      • 中國
      • 印度
      • 日本
      • 韓國
      • 亞太其他地區
  • 中東和非洲
    • 各區域關鍵動態

第9章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第10章：公司簡介

  • 3M
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Stryker Corporation
  • ICU Medical
  • Baxter International Inc
  • GE Healthcare
  • Belmont Medical Technologies
  • IndexIndes
  • Keewell Medical Technology Co., Ltd
  • Narang Medical Limited
  • Biegler GmbH

第 11 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 12 章：附錄

簡介目錄
Product Code: MD9383

The global blood warmer devices market reached US$ 1.38 billion in 2024 and is expected to reach US$ 12.11 billion by 2033, growing at a CAGR of 24.2% during the forecast period 2025-2033.

Blood warmer devices are medical equipment that raise the temperature of blood and intravenous fluids before administration to patients, preventing hypothermia during surgeries, trauma care, or massive blood transfusions. They ensure fluids match the patient's body temperature, reducing complications like cardiac arrhythmias and coagulopathy. They are widely used in hospitals, emergency medical services, military settings, and critical care units to enhance patient safety and improve clinical outcomes.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Hypothermia

The global blood warmer devices market is growing due to the increasing prevalence of hypothermia, a common risk in surgical procedures, trauma cases, and emergency medical situations. Healthcare facilities are increasingly adopting blood warmer devices to ensure safe and effective temperature regulation during fluid and blood transfusions. The growing awareness of hypothermia-related risks and advancements in blood-warming technology are driving market demand, making these devices essential in modern medical care.

For instance, according to NCBI studies 2024, in the US, 700- 1500 hypothermia-related fatalities occur annually, primarily affecting adults aged 30-49, with men experiencing a 10 times higher incidence. Despite optimized in-hospital care, the mortality rate of moderate to severe hypothermia approaches 50%.

High Cost of Advanced Blood Warmer Devices

The high cost of advanced blood warmer devices, particularly in low- and middle-income countries, hinders market growth. These devices require substantial investment and are less accessible to smaller healthcare facilities and emergency services. The cost of maintenance, disposable accessories, and regulatory compliance adds to the financial burden on healthcare providers. This affordability barrier restricts widespread adoption, especially in regions with inadequate healthcare funding. To overcome this, strategic efforts like price reductions, government support, and cost-effective solutions are needed to enhance accessibility and improve patient care worldwide.

For instance, blood warmer devices are crucial medical tools used to heat blood and intravenous fluids before transfusions, preventing hypothermia and enhancing patient safety. Prices in India vary based on brand, features, and technology, ranging from USD 250 for basic models to USD 2,000 for advanced systems.

Segment Analysis

The global blood warmer devices market is segmented based on product type, technology, end-user and region.

Product Type:

The portable blood warmers from the product type segment are expected to dominate the blood warmer devices market with the highest market share

Portable blood warmers are lightweight medical devices used to heat blood and intravenous fluids before administration, especially in emergency and field settings. They are commonly used in ambulances, military operations, and pre-hospital care to prevent hypothermia in trauma patients. Operating on battery power or external power sources, they are ideal for remote locations and critical care transport.

The portable blood warmer market is driven by the growing demand for emergency medical services and military healthcare, particularly in cases of trauma, accidents, and battlefield injuries. Advancements in battery-operated, lightweight technologies have made them more accessible for field applications. The adoption of air and ground ambulances, stringent healthcare regulations, and expanding healthcare infrastructure in remote and rural areas are also driving market growth.

For instance, in June 2024, Danish MedTech company, MEQU, has received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its portable blood & IV fluid warmer system, the °M Warmer System. The FDA clearance marks a significant milestone for the company, marking the end of over a decade of product development. The company is excited to assist U.S. healthcare professionals in saving lives with the M Warmer System.

Geographical Analysis

North America is expected to hold a significant position in the blood warmer devices market with the highest market share

North America dominates the global blood warmer devices market due to its established healthcare infrastructure, rise in product launches, advanced medical technologies, and increasing surgical procedures. The rising prevalence of hypothermia in trauma and surgical patients, along with the increasing number of blood transfusions, drives demand for these devices in hospitals and emergency care settings.

For instance, in June 2023, ICU Medical, Inc., a global leader in medical device development, has introduced the Level 1 H-1200 Fast Flow Fluid Warmer, a vital tool for heating blood, blood products, and intravenous solutions in hospital settings, particularly for patients experiencing blood loss, hypothermia after surgery, or urological irrigation.

Moreover, Key market players, continuous technological advancements, and government initiatives to improve patient safety contribute to market growth. North America also benefits from military and pre-hospital emergency services that require portable, efficient blood-warming solutions.

Competitive Landscape

The major global players in the blood warmer devices market include 3M, Stryker Corporation, ICU Medical, Baxter International Inc., GE Healthcare, Belmont Medical Technologies, Indes, Keewell Medical Technology Co., Ltd, Narang Medical Limited and Biegler GmbH, among others.

Key Developments

  • In August 2024, the Delta Development Team introduced the Single Unit Blood Warmer (SUBW), a revolutionary prehospital blood delivery device that has passed rigorous FDA testing. The device is set to revolutionize blood-warming technology for military operations, rural emergency rooms, and emergency response teams, and is on track for a 510(k) submission.
  • In April 2024, Babson Diagnostics developed a unique hand-warming technology for blood testing, specifically designed for high-quality blood samples from fingertips. The technology, developed in collaboration with biomedical engineering experts, is a step towards addressing the lack of off-the-shelf solutions for blood collection from fingertips. The hand-warming method is a common method used to aid blood collection, but Babson's innovative approach addresses the unique needs of its customers.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global blood warmer devices market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Prevalence of Hypothermia
      • 3.1.1.2. Advancements In Portable and Battery-Operated Blood Warmer Technologies
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Advanced Blood Warmer Devices
      • 3.1.2.2. Stringent Regulatory Approvals and Compliance Requirements
    • 3.1.3. Opportunity
      • 3.1.3.1. Integration of IoT And AI-Based Monitoring Systems for Precise Temperature Control
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Portable Blood Warmers*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Non-Portable Blood Warmers

6. By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Dry Heat Plate Warmers*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Water Bath Warmers
  • 6.4. Infrared Warmers

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals & Clinics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Emergency Medical Services

8. Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. Latin America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Mexico
      • 8.4.6.2. Brazil
      • 8.4.6.3. Argentina
      • 8.4.6.4. Rest of Latin America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. 3M*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Stryker Corporation
  • 10.3. ICU Medical
  • 10.4. Baxter International Inc
  • 10.5. GE Healthcare
  • 10.6. Belmont Medical Technologies
  • 10.7. IndexIndes
  • 10.8. Keewell Medical Technology Co., Ltd
  • 10.9. Narang Medical Limited
  • 10.10. Biegler GmbH

LIST NOT EXHAUSTIVE

11. Assumptions and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us